Fasenra approved in the US for self-administration in a new pre-filled auto-injector, the Fasenra Pen Read more
Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases Read more
Prometheus Biosciences Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease Read more
Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company Read more
Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development Read more
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening Read more
Thermo Fisher Scientific Enhances Leading Pharma Services Offering by Expanding API Manufacturing Capabilities Read more